The Next Generation Cancer Therapies conference will explore new technical approaches to the identification and development of novel cancer therapeutics, including agents in early clinical development. The aim is to provide an accessible insight into recent developments in this rapidly evolving field, that aims to harness our insights from cancer research for the benefit of patients.
The target audience for this conference is: scientists in academia and industry who are interested in the most recent developments in cancer therapeutic discovery, including small molecule, degrader, peptide, and antibody technologies. The conference will include several novel antitumour approaches in early clinical development.
Join this online event on 24 and 25 September to learn more about this fascinating topic from world-renowned speakers. Submit your abstract before 29 July and register before 09 September to secure your place.
More information on the Next Generation Cancer Therapies conference, the programme and the speakers, please visit the website of the European Association for Cancer Research here.
Back